FDA Approved: BORTEZOMIB — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a generic version of bortezomib under an Original Application (ANDA210824) by BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)